Welcome Rite Aid Shareholders!

At Rite Aid we believe our shareholders are incredibly important. We have created this page to help further communicate our results and strategy as well as assist our valued shareholders with easy to navigate answers to some of their most common questions. We have also teamed with Stockperks to reward our shareholders for their continued support. Please check back often for new updates and new video messages.

Sign Up for Stockperks

Enter for a chance to win a tour of the New York Stock Exchange with Rite Aid's Investor Relations team.

Download the Stockperks app to enter*

*open to all RAD shareholders

Latest Events

Rite Aid Investor Facts

FY23Q3 Results

$121.9M

Adjusted EBITDA

$6.1B

Total Revenue

+7.5%

Same Store Sales

+9.5%

Same Store Pharmacy Sales

+8.0%

Acute Scripts


(excluding COVID immunizations)

2025

No Debt Due

FAQs Click here